Translation of "Fat embolism" in German

You know, maybe we should be worried about a fat embolism.

Fat embolism occurs much more frequently after other surgical operations and bone fractures.

This is unacceptable for reasons which have already been described (danger of fat embolism).

It prevents the development of fat embolism.

Fat embolism is a very rare, however possible, complication.

Each operation makes a general anaesthetic and blood transfusions necessary, it also contains the risk of fat-embolism.

Uncommon side effects (affects in 1 to 10 users in 1,000 include: anxiety, dermal and visual hypersensitivity ), migraine, mini stroke (transient ischaemic attack), fat entering the circulatory system (fat embolism), vein blockage and inflammation (thrombophlebitis), blockage in a lung artery (lung embolism), itching scar, pain at the front of the knee (chondromalacia), breakdown of knee tissue (gonartrhosis, atrophy), discomfort, chronic inflammation (granulomatous lesion).

During the work involved in introducing the cement, or when introducing the prosthesis, excavated material present in the honeycombs of the spongy substance can be forced into the blood flow and trigger a fat-embolism syndrome.

Causative conditions that can be connected with consumption coagulopathy include bacterial shock, burns, carcinoma, leukemia, amniotic embolism, fat embolism, acidosis, hypoxemia, bacteriemia, virus diseases, organ transplants, and anaphylactic shock.

The use of solutions of carotenoids as molecular dispersions in oils or oil-soluble substances is problematic for injections and entirely unsuitable for administration directly into the bloodstream because there is a risk of fat embolism.

Particularly important in this connection are the particle size--particles larger than 1 ?m may lead to fat embolism--the systemic and local tolerability and the hemolytic activity.

Thus, in case of a commercial production, the risk of a fat embolism through the lipophilic active agent is less, because it does not precipitate in the blood.

Side effects are among others pain, erythema and oedema while the risk of a fat embolism is only very little when using blunt canulas.

As a result, Interruptin was used frequently until the problematic side effects became noticeable: more and more deaths were caused by air or fat embolism.

The applied active ingredient phosphatidylcholine (Lipostabil) is a natural substance obtained from soya beans, which has been used in medicine for many years to treat dysfunctions in fat metabolising as well as fat embolism.

So in addition to other important rules as careful preparation techniques (Hofmann 1999, Wenda 1993) the tested hollow rasp design can get a simple, but important tool to minimize the risk of bone marrow intravasation and to subsequently prevent fat embolism with cardiorespiratory deterioration.

It provides us with a method of effectively reducing without resorting to surgical intervention The applied active ingredient phosphatidylcholine (Lipostabil) is a natural substance obtained from soya beans, which has been used in medicine for many years to treat dysfunctions in fat metabolising as well as fat embolism.

This is because the fat must be very carefully transplanted to ensure it does not enter any veins, which could potentially lead to fat embolism (fat entering the heart and lungs, which could result in death).

The infiltration of the constituents of the medullary cavity into the blood flow (fat-embolism syndrome) is reduced since, on the one hand, no excavated material can be forced out of the honeycombs of the spongy substance into the blood flow, and, on the other hand, the open structure of the instrument prevents a pathological buildup of pressure.

The matrix former should always be applied in small quantities only, in very thin layers onto the implant surtace in order to avoid the risk of fat embolisms occurring.

Therefore the reduction of intramedullar pressure for this preparation step is an essential aim to minimize the fat embolic risks.

Although the blood is mechanically filtered by the microfilter prior to transfusion, small clots, less than 40 ?l in size, of fat and activated clotting factors nevertheless can enter the circulatory system of the patient, so that the risk of thromboembolic complications and fat embolisms cannot be precluded, which is extremely disadvantageous.